Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Savara SVRA Q1 2026 Results Fall Short EPS 015 Revenue NA Anthropic Expands AI Talent with Former Tesla and OpenAI Leader as SpaceX Collaboration Deepens Apyx Medical APYX Stock Down 444 Support Test at 368 20260518 Is WaterBridge WBI Still a Buy After 068 Rally 20260518 Numero AI and Royu Merge to Reshape Finance Operations with Agentic Workflows NFL Seeks Ban on Prop Bets and Injury Contracts in Prediction Markets Citing Integrity Concerns Alumis ALMS Q1 2026 Earnings Surge EPS 074 vs 078 Forecast US Appeals Court Dismisses Whistleblower Tariff Fraud Claims Against Amazon Nvidias Earnings Highlight 200 Billion Opportunity and Edge Computing Despite China Concession Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday White House Ceremony Planned SP 500 Extends Gains as Healthcare and Tech Lead Broad Rally Wall Street Edges Higher Led by Healthcare and Tech Gains Disneys The Mandalorian and Grogu Opens to 82 Million Weakest Star Wars Debut Yet Geopolitical Tensions Escalate as Iran Refuses Concessions Amid Strait Dispute Oil Markets on Edge BHC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Uncertainty FNV Q1 2026 Earnings Strong EPS Beat Driven by Higher Streaming and Royalty Revenues PYPD Q1 2026 Earnings EPS Beat on Operational Discipline But Revenue Remains Absent GEN Q1 2026 Earnings EPS Beats Estimates by 201 Despite Modest Stock Decline Green Plains GPRE Q1 2026 Earnings Massive EPS Beat of 63555 Drives Stock Higher TSM Q1 2026 Earnings EPS Crushes Estimates as AI Demand Fuels Record Profitability NVNI Q4 2025 Earnings Significant EPS Miss Surprises Stock Still Climbs Over 8 PHM Q1 2026 Earnings Earnings Miss Estimates as Costs Outweigh Demand STOK Q1 2026 Earnings EPS Surprises to the Upside as Clinical Pipeline Advances ARE Q1 2026 Earnings Massive EPS Surprise Highlights Operational Strength ORIC Q1 2026 Earnings Narrower Loss Misses Estimates as Clinical Development Continues